Health
Despite COVID-19 setbacks, WHO aims to eliminate lymphatic filariasis by 2030 – News-Medical.Net
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk…
Reviewed by Emily Henderson, B.Sc.Nov 2 2020
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk of the disease, as recommended by the World Health Organization (WHO).
Seventeen countries achieved the criteria for elimination of LF as a public health problem; Kiribati, Malawi and Yemen were the latest to be acknowledged by WHO.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF)…
Continue Reading